Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Tai-Guang Jin"'
Autor:
Chaomei Shi, Mikhail Levit, Tai-Guang Jin, Dinesh S. Bangari, Zhihu Ding, Tatiana Tolstykh, Karl Mamaat, Joern Hopke, Susan Ryan, Lan Jiang, Hui Cao, Qunyan Yu, Dietmar Hoffmann, Hui Qu, Liang Schweizer, Sabine Scheidler, Fangxian Sun, Douglas D. Fang, May Cindhuchao, Christopher Winter, Dmitri Wiederschain, Jack Pollard, Mike W. Helms, Kerstin Jahn-Hofmann
Publikováno v:
Oncotarget
Hepatocellular carcinoma (HCC) represents a serious public health challenge with few therapeutic options available to cancer patients.Wnt/β-catenin pathway is thought to play a significant role in HCC pathogenesis. In this study, we confirmed high f
Autor:
Rui Niu, Chengang Zhou, Zheng Zhou, Lisha Wang, Alexander V. Mayweg, Zhiheng Xu, Tai-Guang Jin, Min Jiang, Song Yang, Xingchun Han
Publikováno v:
Bioorganicmedicinal chemistry letters. 27(18)
A fragment library screen was carried out to identify starting points for novel CDK8 inhibitors. Optimization of a fragment hit guided by co-crystal structures led to identification of a novel series of potent CDK8 inhibitors which are highly ligand
Autor:
Lu Xianping, Zheng Hong Peng, Lichun Feng, Lei Guo, She Jin, Yun He, Song Pan, Junli Chen, Zhenshan Zhang, Shan Song, Yiping Rong, Li Chen, Ying Ji, Chao Zhang, Shijie Li, Chunping Xu, Rong Zhao, Yongfu Liu, Yi Ren, Xihan Wu, Weixing Zhang, Xianfeng Lin, Tai-Guang Jin, Jason Christopher Wong, Taiping Chen, Jie Cai, Dawei Chen, Jianghua Mei, Meifang Zhang, Shuang Ren, Chungen Liang, Weili Zhao, Mingwei Zhou, Xiongwen Zhang, Zhanguo Wang, Zhiqiang Ning, Guozhi Tang, Desi Pan, Nan Zhang
Publikováno v:
Journal of Medicinal Chemistry. 55:8903-8925
Herein, we describe the pharmacokinetic optimization of a series of class-selective histone deacetylase (HDAC) inhibitors and the subsequent identification of candidate predictive biomarkers of hepatocellular carcinoma (HCC) tumor response for our cl
Autor:
Dinesh S. Bangari, Zhihu Ding, Joern Hopke, Tatiana Tolstykh, Dmitri Wiederschain, May Cindhuchao, Hui Qu, Chaomei Shi, Mike W Helms, Christopher Winter, Kerstin Jahn-Hofmann, Karl Mamaat, Susan Ryan, Liang Schweizer, Lan Jiang, Fangxian Sun, Qunyan Yu, Sabine Scheidler, Mikhail Levit, Jack Pollard, Dietmar Hoffmann, Hui Cao, Tai-Guang Jin, Douglas D. Fang
Publikováno v:
Cancer Research. 78:2489-2489
Introduction: Hepatocellular carcinoma (HCC) is the 3rd leading cause of cancer-related mortality. Currently there are few treatment options available for advanced HCC patients. Multi-kinase inhibitors sorafenib and regorafenib are the only approved
Autor:
Jack Lawler, Xuefeng Zhang, Nordine Benhaga, Sareh Parangi, Min Ye, Robin Humphreys, Roya Khosravi-Far, Keli Song, Tai-Guang Jin, Mark Duquette, Bin Ren
Publikováno v:
Cancer Research. 69:3856-3865
As tumor development relies on a coordination of angiogenesis and tumor growth, an efficient antitumor strategy should target both the tumor and its associated vessels. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis
Autor:
Philimon Gona, Tai-Guang Jin, Kenneth Ndebele, Roya Khosravi-Far, Nordine Benhaga, Mauro Degli-Esposti, Anas Chalah
Publikováno v:
Apoptosis. 13:845-856
Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) initiate pathways of cell death in which caspase activation is mediated either directly (without mitochondrial amplification), or indirectly via the release of apoptogenic factors
Autor:
Brian K. Kay, Mehrdad Mohseni, Karon Abe, Keli Song, Nordine Benhaga, Ferry Sandra, Alexei Kurakin, Roya Khosravi-Far, Tai-Guang Jin
Publikováno v:
Journal of Biological Chemistry. 279:55594-55601
Here we show a novel mechanism by which FLICE-like inhibitory protein (c-FLIP) regulates apoptosis induced by tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and one of its receptors, DR5. c-FLIP is a critical regulator of the T
Autor:
Roya Khosravi-Far, Xiaoping Zhang, Tai-Guang Jin, Hongmei Yang, William C. DeWolf, Aria F. Olumi
Publikováno v:
Cancer Research. 64:7086-7091
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been shown to induce apoptosis in a variety of tumorigenic and transformed cell lines but not in many normal cells. Hence, TRAIL has the potential to be an ideal cancer therapeutic a
Publikováno v:
Journal of Biological Chemistry. 276:28478-28483
We previously identified RA-GEF-1, a novel guanine nucleotide exchange factor (GEF) for Rap1 with the ability to associate with Rap1.GTP at its Ras/Rap1-associating (RA) domain. Because it possesses a PSD-95/DlgA/ZO-1 (PDZ) domain, it was also named
Autor:
Masahiro Goshima, Yanhong Liao, Tomoyo Okada, Yasuhiro Watari, Tohru Kataoka, Yuriko Yamawaki-Kataoka, Xianlong Gao, Mitsushige Shibatohge, Chang-Deng Hu, Ken-ichi Kariya, Tai-Guang Jin
Publikováno v:
Journal of Biological Chemistry. 274:37815-37820
A yeast two-hybrid screening for Ras-binding proteins in nematode Caenorhabditis elegans has identified a guanine nucleotide exchange factor (GEF) containing a Ras/Rap1A-associating (RA) domain, termed Ce-RA-GEF. Both Ce-RA-GEF and its human counterp